310 results on '"Somvanshi, Pallavi"'
Search Results
52. Gene Cloning, Expression, and Characterization of Recombinant Aerolysin from Aeromonas hydrophila
53. High throughput prediction and analysis of small interfering RNA from the 5′UTR and capsid genes of flavivirus through in silico strategies
54. Structural Modeling of the NS 3 helicase of Tick-borne encephalitis virus and their virtual screening of potent drugs using molecular docking
55. Homology modelling of 3-oxoacyl-acyl carrier protein synthase II from Mycobacterium tuberculosis H37Rv and molecular docking for exploration of drugs
56. Investigating the function of single nucleotide polymorphisms in the CTSB gene: a computational approach
57. Bioinformatics
58. Prioritization and characterization of validated biofilm blockers targeting glucosyltransferase C of Streptococcus mutans
59. The polyphenolic phytoalexin polydatin inhibits amyloid aggregation of recombinant human prion protein
60. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein
61. Identifying novel inhibitor of quorum sensing transcriptional regulator (SdiA) of Klebsiella pneumoniae through modelling, docking and molecular dynamics simulation
62. Structure-Based Screening of Non-β-Lactam Inhibitors against Class D β-Lactamases: An Approach of Docking and Molecular Dynamics
63. Potency of inhibitors depends upon the accessibility of their aromatic rings within the hydrophobic specificity pocket: a novel avenue for future aldose reductase inhibitor design
64. Homology Modeling of Adenosine A2a Receptor and Molecular Docking for Exploration of Appropriate Potent Antagonists for Treatment of Parkinsonʼs Disease
65. Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery
66. Inhibition of Oligomerization of Aerolysin from Aeromonas Hydrophila: Homology Modeling and Docking Approach for Exploration of Hemorrhagic Septicemia
67. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
68. Investigation of precise molecular mechanistic action of tobacco-associated carcinogen 'NNK´ induced carcinogenesis
69. Antineoplastic action of sulforaphane on HeLa cells by modulation of signaling pathways and epigenetic pathways.
70. Molecular detection and cloning of thermostable hemolysin gene from Aeromonas hydrophila
71. MOESM1 of Methodology of predicting novel key regulators in ovarian cancer network: a network theoretical approach
72. Unravelling the interaction of glipizide with human serum albumin using various spectroscopic techniques and molecular dynamics studies
73. Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
74. Ameliorating amyloid aggregation through osmolytes as a probable therapeutic molecule against Alzheimer's disease and type 2 diabetes
75. Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells
76. In silico screening of potential lead compounds against 3-oxo-5-alpha-steroid 4-dehydrogenase 2 for treating prostate cancer
77. Comparative assessment of the therapeutic drug targets of C. botulinum ATCC 3502 and C. difficile str. 630 using in silico subtractive proteomics approach
78. Drug repurposing against arabinosyl transferase (EmbC) of Mycobacterium tuberculosis: Essential dynamics and free energy minima based binding mechanics analysis
79. Identifying novel inhibitor of quorum sensing transcriptional regulator (SdiA) of Klebsiella pneumoniae through modelling, docking and molecular dynamics simulation.
80. Potency of inhibitors depends upon the accessibility of their aromatic rings within the hydrophobic specificity pocket: a novel avenue for future aldose reductase inhibitor design.
81. Unravelling the interaction of glipizide with human serum albumin using various spectroscopic techniques and molecular dynamics studies.
82. Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis : Dynamics of essential motions and free‐energy landscape analysis
83. Inhibition of C298S mutant of human aldose reductase for antidiabetic applications: Evidence from in silico elementary mode analysis of biological network model
84. Identifying novel inhibitor of quorum sensing transcriptional regulator (SdiA) of Klebsiella pneumoniaethrough modelling, docking and molecular dynamics simulation
85. In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus
86. Aspartate‐β‐semialdeyhyde dehydrogenase as a potential therapeutic target of Mycobacterium tuberculosis H37Rv: Evidence from in silico elementary mode analysis of biological network model
87. Association of Inflammatory Bowel Disease with Arthritis: Evidence from In Silico Gene Expression Patterns and Network Topological Analysis
88. Pan-genome analysis of Clostridium botulinum reveals unique targets for drug development
89. Simulation Based Investigation of Deleterious nsSNPs in ATXN2 Gene and Its Structural Consequence Toward Spinocerebellar Ataxia
90. Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNA Polymerase Beta Subunit of Mycobacterium tuberculosis
91. Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis: Dynamics of essential motions and free‐energy landscape analysis.
92. Comparative proteome analysis of distinct variants of dengue virus using insilico approach
93. Phylogenetic investigation of lin genes involved in degradation of Hexachlorocyclohexane (HCH)
94. Phylogenetic and computational proteome analysis of influenza a virus subtype H5N1
95. Assessing the precision of high-throughput computational approaches for the genome-wide subcellular localization of putative proteins from vibrio cholerae
96. Insilico primer designing of structural region of Dengue virus for molecular diagnostic
97. Prediction and mapping of IgE motif epitopes in proteins of genetically modified foods for immunotherapy strategy
98. In silico analysis of subcellular localization of putative proteins of Mycobacterium tuberculosis H37Rv strain
99. Mechanistic Insights into the Binding of Class IIa HDAC Inhibitors toward Spinocerebellar Ataxia Type-2: A 3D-QSAR and Pharmacophore Modeling Approach
100. Human Caveolin-1 a Potent Inhibitor for Prostate Cancer Therapy: A Computational Approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.